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ABSTRACT  
Arthritis and various musculoskeletal disorders are the leading causes of 
disability in persons between 18 to 65 years of age and are common causes of 
disability related to employment. Among them Rheumatoid arthritis is a 
common clinical condition characterized by pain, stiffness and inflammation of 
joints with varying degree of disability. In this study 50 patients (age group 
between 20-60 yrs) diagnosed as RA after assessing both objective and 
subjective parameters have undergone the prescribed classical Ayurvedic 
treatments, both IP and OP level to evaluate its effect in the functional 
improvement. The study period was totally 57 days which includes 21 days each 
at inpatient and outpatient basis and 15 days of follow up. Initial course was 
Ama pachana treatments for 7 days. It includes Pachana medicines internally 
and Ruksha pottali sweda externally. Next 14 days, Samana medicines internally 
and Pathra pottali sweda externally were given. Same internal medicines and oil 
application were continued for next 21 days as outpatient. The response of 
treatment was assessed periodically with respective parameters and were 
showed significant effect. The improvement in functional assessment evaluated 
by using the Das 28 score, disability index, quality of life index -SF36 and global 
assessment of disease activity scale are all found significant changes. The lab 
parameters used to evaluate the liver and kidney function did not show any 
adverse changes that shows the prescribed treatment is safe. 
INTRODUCTION 
Rheumatoid arthritis is a systemic connective 
tissue disorder not only affects the synovial joints but 
may affect almost all the tissues or organ systems in the 
body. Among the musculoskeletal disorders it is a very 
common and distressing clinical condition owing to its 
chronic nature, crippling deformities and pain. The 
changing life style, climatic conditions and dietetic 
pattern are the chief contributing factors for the onset of 
the disease. It is reported that about 40 per cent become 
work disabled within five years from onset of symptoms 
with significant decline in functional capacity and the 
number of affected patients is increasing day by day. The 
prevalence of RA is ~0.8% of the population (range 0.3-
2.1%); women are affected approximately three times 
more often than men1. 
Rheumatoid arthritis is an autoimmune disease 
with characteristic feature of inflammatory synovitis, 
typically in a symmetrical pattern which leads to erosive 
changes inside the joint. Usually certain specific joints 
such as the proximal interphalangeal and 
metacarpophalangeal joints are affected and the distal 
interphalangeal joints are rarely involved. Recent 
evidence suggests that antibodies to CCP (cyclic 
citrullinated peptide), which are generated within the 
synovium is the contributing factor for the synovitis2. 
Ayurvedic review 
The pathogenesis and clinical features of RA 
cannot be correlated to a specific disease entity 
described in Ayurveda. One can find in the descriptions 
of Vatarakta in classical Ayurvedic treatises as a 
spectrum of diseases that includes rheumatological, 
musculoskeletal, and other pathological conditions of 
skin and blood vessels. As such it may be noted that the 
pathogenesis and clinical features of the diseases, 
Rheumatoid arthritis, Gout, Psoriatic arthritis, Systemic 
lupus erythematosus, Cellulitis, Deep vein thrombosis, 
Thromboangitis obliterens etc. are comes under the per 
view of the broad diagnosis of Vatarakta. 
According to Ayurvedic principles the irregular 
and injudicious dietary practices and physical activities 
are the causes for Agnimandya (indigestion) due to the 
disturbed Pitta dosha and its outcome is degraded Rasa 
dhatu. There exist the primary level Dosha sanchaya in 
Koshta and it characteristically affects the qualities of 
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Rasadhatu which is being converted into Rakta dhatu. 
The Rasadhatu that contains the “Ama”, the outcome of 
improper digestion of food which is immunologically 
incompetent, is capable of vitiating Rakta dhatu during 
the course of Parinama. In this stage Vruddhi and 
Prakopa of Vata dosha may occur due to its own 
etiological factors and it interacts with Ama dosha 
leading to the functional disturbance of target organs. In 
the context of rheumatoid arthritis primarily there is a 
Dosha predominance of Vatakapha with the 
characteristic features of “Ama” in initial phase. The 
pathological processes initiated in this stage produces 
acute inflammatory response in the body with the 
clinical manifestation of soft tissue swelling or fluid 
effusion in the joints along with pain, general weakness, 
heaviness in the body, loss of appetite etc. This stage is 
considered as separate entity of disease Amavata and 
described in detail with Nidana, Samprapthi, Lakshana 
etc by the later text books of Ayurveda like 
Madhavanidana3, Bhaishajya ratnavally4, Chakradatha5 
etc. 
In chronic disease conditions or after subsidence 
of “Ama” due to “Amapachana” measures the vitiated 
Vata interacts with Rakta and secondary level changes 
takes place in the target organs, Sakhas and Asthi sandhis. 
The functional disturbance of Vata dosha leads to the 
obstruction of Rakta in respective sites especially in 
peripheral vessels. Here the basic properties of Vata, 
such as Sukshmatva, Chalatva6, etc and Saratva, 
Dravatva7 of Rakta are at work. As a result, the 
inflammatory processes actively centered at the affected 
joints makes severe damage to the structures 
participating in the joints. Obviously it is noted that the 
protective enzymes released due to the activities of 
lymphocytes and plasma cells –lysosomal enzymes-in the 
proliferated synovium leads to the digestion and erosion 
of hyaline cartilage which forms a covering of bony ends 
participated in the joints. When these changes are 
localized at joints and soft tissues the clinical features of 
Vata and Rakta predominance can be observed. All these 
pathological events will lead to severe degenerative 
changes in the joints and associated structures that can 
progress to various types of deformities in future. 
 In allopathic system of medicine NSAIDs are 
used for control of inflammation and related symptoms 
and the long term suppression is achieved by the 
DMARDs. But most of the NSAIDs have gastrointestinal 
side effects such as gastric ulcers with bleeding and 
perforations. Glucocorticoids have substantial effect on 
joint pain than NSAIDs but have many side effects 
including adrenal suppression, ulcers and osteoporosis. 
DMARDs reduce the progression of joint erosion but no 
analgesic activity and act slowly. Methotrexate also has 
the side effects like bone marrow, renal and hepatic 
suppression. None of the therapeutic interventions is 
curative, and therefore all must be viewed as palliative, 
aimed at relieving the signs and symptoms of the disease. 
Hence, these medications are not safe and fully effective 
in the management8.  
Many studies have been conducted in various 
research and academic institutions to evaluate the 
efficacy and safety of herbal preparations as well as 
effect of various Panchakarma and related Ayurvedic 
procedures in the management of Rheumatoid arthritis. 
Publication of research articles in JRAS and 
other reputed journals on RA are also available. Classical 
methods of management for RA with Sodhana therapy 
followed by Kalavasti is said to have significant effect 
(PKS nair et al)9. Study of Kshara basti and Nirgundi 
ghana vati (Krishna thanki et al.)10 Vardhamana pippali 
rasayana (Patel.K etal.) 11 Alambushadi compound and its 
vasti in the management of Amavata (Rheumatoid 
Arthritis)12. Amrita Bhallathaka avaleha and Virechana 
karma (Priti Sharma et al)13 Efficacy and safety of 
Ashwagandha and Siddha Makaradhwaj in Rheumatoid 
arthritis patients (Gajendrakumar et al.)14 are few among 
them. All these studies have shown significant effect by 
the prescribed therapeutic procedure at various levels in 
the management of Rheumatoid arthritis. 
The management programme of Rheumatoid 
arthritis is to be planned based on the involvement of 
Dosha dushya involvement in pathogenesis and the stage 
of the disease. In the initial stage of the disease or during 
the presence of “Amatva’ that designated as Amavata, the 
treatment should be focused on Ama pachana and 
Srothosodhana. After the course of Ama pachana 
procedures the next programme should be Vata rakta 
Samana and regenerative in effect to reconstruct the 
degenerated tissues to avoid deformities at joints. In 
clinical practice, the Ayurvedic methods of management 
has been found very effective in relieving the distressing 
symptoms - pain, inflammation, protection of articular 
structures, maintenance of function, and control of 
systemic involvement. Hence in this study a systematic 
treatment programme based on the “Ashtavaidya” 
practices of Kerala is designed for the evaluation of the 
effect of functional improvement of Rheumatoid arthritis 
patients and the safety of the procedure. 
MATERIALS AND METHODS 
The present study is a prospective, open label, 
non randomized, single centered clinical trial conducted 
in the Ayurveda Research Foundation Hospital of the 
Vaidyaratnam group of institutions, Ollur, Thrisur, 
Kerala. It was carried out during the period of 2011-16 
under Center Of Excellence research programme allotted 
by Ministry of AYUSH, Govt. of India. The trial 
programme was approved by the institutional ethics 
committee and the study was registered with Clinical 
Trial Registry of India. The protocol of the study and the 
CRF was approved by CCRAS, New Delhi. The patients 
attended with the clinical features of Rheumatoid 
arthritis in the OPD of Vaidyaratnam Ayurveda Research 
Foundation Hospital were subjected for the screening 
according to the inclusion criteria and American college 
of rheumatology (ACR) 2010 criteria. Exclusion criteria 
were patients who develop secondary complication of 
RA, severely damaged joints, unable to walk without 
support/ confined to wheelchair or bedridden, other 
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types of arthritis with serious complications like bursitis, 
osteoporosis, steroid dependent patients / prolonged 
medications – anti depressants etc. Patient with poorly 
controlled Hypertension/Diabetes mellitus, Cardiac 
disease/ Heart failure, Pulmonary tuberculosis, Hepatic 
disorder, Alcoholic/ drug abuser, Pregnant women etc 
are also excluded. 
Total No of 50 patients who fulfilled the above 
inclusion criteria were selected and enrolled for the 
study. The patients belong to both sex and age group 
between 20 and 60 years. All the selected patients were 
submitted the written informed consent to undergo the 
study as per the programme and undergone detailed 
clinical examination based on the CRF prepared that 
includes both Ayurvedic and modern parameters with 
respect to the physical characteristics of patients and 
disease conditions. 
Treatments and medicines 
 The course of treatment includes inpatient and 
outpatient level of 21 days each. In the initial course of 
treatment at IPD 7 days has been allotted for 
“Amapachana” measures. Amruthotharam kwatha and 
Vaiswanara churna internally and Ruksha pottali sweda 
with Syamaka churna externally were given during this 
period. The next 14 days in IPD Rasnasapthakam kwatha 
and Vyoshadi gulgulu churna internally and Pathrapottali 
Sweda externally were tried. The patients were 
discharged from IPD and advised to continue the internal 
medicines for a period of 21 days at OPD level. During 
this period advised to do body massage with 
Kottamchukkadi taila and apply Balaguluchyadi taila 
over the scalp. All the cases were followed up for 15 
days. 
Table 1: Treatment schedule 
Internal External 
Medicine Dose Time No. of days Procedure Drug 
Amrithotharam Kwatha15 
Vaiswanara churna16 
100ml 
3gms 
6am & 6pm 
6am & 6pm 
7 
7  
Ruksha pottali 
sweda19, 21 
Syamaka churna 
Rasnasapthakam Kwatha17 
Vyoshadi gulgulu churna 18 
100ml 
3gms 
6am & 6pm 
6am & 6pm 
14 
14 
Pathrapottali 
sweda20, 21 
Kottamchukkadi taila-22 
Balaguluchyadi taila23 for scalp. 
The trial medicines were prepared in the pharmacy attached to the Vaidyaratnam Oushadhasala as per the procedures 
described in Ayurvedic formulary of India and under gone strict quality control methods as prescribed. 
Clinical assessment 
The assessment of result was made based on the scores provided to each signs and symptoms recorded 
periodically on 7th, 21st, 42nd and 57th day, and compared the changes to the baseline (0 day).Visual analogue scale 
was used to make assessment of pain by marking the severity by the patients themselves periodically. The 
improvement in functional assessment was evaluated by using the Das 28 score, Disability index, quality of life index 
SF36 and global assessment of disease activity scale. 
Laboratory investigations were performed for all patients at baseline and after the full course of study. It 
includes routine haemogram, blood biochemistry for blood sugar, serum cholesterol, blood urea, uric acid, s.creatinin, 
SGOT, SGPT, S.Bilirubin, Alkaline phosphatase etc and immunological test for ACCP, RA factor, CRP and ASO. X-ray of 
affected joints and ECG of patients was also taken.  
Observation and Results 
The observations described here are based on the clinical study of 50 cases of Rheumatoid arthritis. Among 
them the majority were females (80%) and the predominant age group affected was 51-60years. 
Table 2: Distribution of patients according to age and sex 
Age 
group 
Female Male Total 
Count Percent Count Percent Count Percent 
21-30 3 7.5 2 20.0 5 10.0 
31-40 9 22.5 0 0.0 9 18.0 
41-50 9 22.5 6 60.0 15 30.0 
51-60 19 47.5 2 20.0 21 42.0 
Total 40 100.0 10 100.0 50 100.0 
P-value = 0.028 
As the all frequencies are very small Fisher’s exact test was done. P-value is less than 0.05 which shows that 
there exists significant difference in the age wise occurrence in male and female. 
The observations on socio demographic characteristic of the patients like educational status, occupation, living 
conditions, religion etc  
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Table 3: Socio-demographic characters of the patients 
Characteristics Category Frequency Percent 
Gender 
Female 40 80.0 
Male 10 20.0 
Marital status 
Married 47 94.0 
Unmarried 3 6.0 
Educational 
status 
Illiterate 4 8.0 
Academically qualified 46 92.0 
Occupation 
Desk Work 8 16.0 
Field work  19 38.0 
House wife 20 40.0 
Unemployed 3 6.0 
Socioeconomic 
Status 
APL 38 76.0 
BPL 12 24.0 
Habitat 
Urban 7 14.0 
Semi-urban 35 70.0 
Rural 8 16.0 
Religion 
Hindu 36 72.0 
Christian 4 8.0 
Muslim 10 20.0 
The Dosha prakruti of patients were analysed using a special proforma and it indicate that majority of patients 
were belongs to Kaphapitta (68%) and Vata pitta (22%) Prakruti. 
Table 4: Distribution of patients based on Dosha prakrithi 
Type Frequency Percent 
Kaphaja 1 2.0 
Vata-Pittaja 11 22.0 
Vata-Kaphaja 4 8.0 
Pitta-Kaphaja 34 68.0 
Total 50 100.0 
Sara analysis showed that 38% were rasa Sara purusha, Raktha and Mamsa sara belongs to 22% each and 14 
% and 4 % are Asthi sara and Medo sara respectively. 
Table 5: Distribution of patients based on Sara 
Type Frequency Percent 
Rasa/Twak 19 38.0 
Rakta 11 22.0 
Mamsa 11 22.0 
Meda 2 4.0 
Asthi 7 14.0 
Total 50 100.0 
The Samhanana condition of the patients showed that 40%, 38 %and 22% were the distribution for Pravara, 
Madhyama and Avara respectively. Among the 50 patients it was observed that 80% were Madhyama satmya and 
remaining 16% and 8% were Avara and Pravara respectively. In Ahara shakthi, it was observed that 66% were 
Madhyama, 32% were Avara and only 2 % were Pravara. While observing the Vyama shakthi, it was seen that 54 % 
were Avara and remaining were Madhyama.  
Table 6: Classification based on physiological characteristics 
Characters Pravara Madhyama Avara 
Samhanana 20 (40) 19 (38) 11 (22) 
Satmya 2 (4) 40 (80) 8 (16) 
Satva 3 (6) 39 (78) 8 (16) 
Ahara shakti 1 (2) 33 (66) 16 (32) 
Vyayama Shakti 0 23 (46) 27 (54) 
Values within brackets are percentages 
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Among the studied patients, the climatic changes had influence in aggravating the disease condition in 58%. 16 % were 
affected with food and weather, 12% were affected with change in food, drink and weather. 14 % reported no specific 
reasons.  
Table 7: Classification based on Aggravating factors 
Factors Frequency Percent 
Nil 7 14.0 
Weather 29 58.0 
Food and weather 8 16.0 
Food, drink and weather 6 12.0 
Total 50 100.0 
The observation on various factors mainly dietary habit showed 80% as non vegetarians and 20 % vegetarian.96% and 
88% were alcoholic and smokers respectively. 45% of the patients had disturbance in sleep, 64% had allergy to some 
material. 72% had moderate stress and 24% had too much stress. Among the patients 22 % of them only had family 
history of RA. The physical structure showed 60% as in average built, 10% were emaciated and 28% were well built. 
86% were moderately nourished, 8% were malnourished and 6% well nourished. 56 % were in normal BMI. 
Among the patients studied 94 % were reported to have insidious onset.  
Table 8: Classification based on Onset of disease 
Onset of disease Frequency Percent 
Acute 3 6.0 
Insidious 47 94.0 
Total 50 100.0 
The chief complaints noted during admission were—pain and swelling in joints along with morning stiffness, 
tenderness, fever and general weakness.  
Table 9: Observations of Chief complaints in patients and it’s percentage 
Complaints No of patients Percentage 
Pain in Joints 50  100 
Swelling in joints 49  98 
Morning Stiffness 48  92 
Tenderness 50  100 
Fever 33  66 
Malaise/fatigue/weakness 48  96 
 The observation regarding the major signs and symptoms at the time of admission of the selected patients 
and its percentage of occurrence is tabulated in the table No.9 
Table 10: The characteristic features of the disease of studied patients 
Observation No of patients percentage 
Presence of Symmetrical Poly arthritis 49  98 
Position of Joints and fixed deformity 12  24 
Sign of Inflammation over the joints 44  88 
Muscle wasting just above the joints 2  4 
Elevated Local temperature 17  34 
Tenderness 49  98 
Swelling 49  98 
Rheumatoid Nodules 7  14 
Pain on movement 50  100 
Restriction of Movement 50  100 
Protective Muscular spasm 31  62 
Disturbed sleep 23  46 
Irregular bowel habit 9  18 
Abnormal urine output 11  22 
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Presence of Ama with reference to the classical features described recorded at the base line and its assessment made 
after the course Amapachana measures is tabulated in the table No-10 
Table 11: Response of treatment with respect to the clinical features of Ama 
Parameters First day 7th day 
Angamarda 47 20**  
 Aruchi 43 3**  
Trsna 36 1**  
Alasya 50 22**  
Gaurava 42 40ns 
Jwara 30 3**  
Apaka 34 2**  
Anga Shunata 47 17**  
Sandhistabthata 48 50ns 
Sandi Ruja 49 50ns 
Bahumutrata 41 4**  
Praseka 19 2**  
Utsahahani 48 26**  
Vairasya 29 2**  
Daha 13 3*  
Kukshi katinata 12 1**  
Shula 17 6*  
Nidraviparyayam 41 31*  
Chardi  6 1ns 
Bhrama  16 2**  
Murcha  4 0*  
Hridgraha  6 2ns 
Vidvibaddhata 15 4*  
Jadya  27 2**  
Antrakujan  7 3ns 
Tivra ruja 50 47*  
Pittanubamdha– daha 13 4*  
Raga 6 2ns 
Gurutva 39 19**  
 Sthaimitya 37 24*  
Kandu 4 1ns 
* Significant at 0.05 level; ** significant at 0.01 level; ns non significant (compared to base line) 
0
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Figure-1,The characteristic features of the disease of studied patients
No of patients percentage
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Table 12: Response of treatment based on chief complaints using t-test 
Parameters Base Line Visit 1 (7th day) Visit 3 (42nd day) Visit 4 (57th day) 
Pain in joints 50 (100) 50 (100)ns 27 (54)** 18 (36)** 
Swelling 49 (98) 50 (100)ns 11(22)** 6 (12)** 
Morning Stiffness 48 (96) 46 (92)ns 5 (10)** 2 (4)** 
Tenderness 50 (100) 46 (92)* 11 (22)** 9(18)** 
Fever 33 (66) 1 (2)* 0** 1 (2)** 
Malaise 48 (96) 26 (52)* 5 (10)** 1 (2)** 
* Significant at 0.05 level; ** significant at 0.01 level; ns non significant (compared to base line) 
Proportion test was used to comparing the percentage of respondents having each symptoms at different visit 
compared to base line. No significant difference in the pain in joints, swelling and morning stiffness was noted in the 
first visit. Percentage of patients having tenderness, fever and Malaise was reduced in the second visit itself compared 
to the base line observations. However from 22nd day on wards highly significant improvement was noted in respect of 
all symptoms compared to base line 
 
Comparison of visual analog score among different time period was compared using Friedman’s test. A significant 
decrease in visual analog score was found from first day to 21st day and then to 42nd day. 
Table 13: Comparison of Visual Analog Score 
Period Mean ± SE 
First day 7.84 ± 0.96a 
21st day 3.42 ± 1.33b 
42nd day 1.96 ± 1.18c 
Chi square value 93.167** 
p-value < 0.001 
  ** Significant at 0.01 level, Means having same letter as superscript are homogenous 
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Figure-2, Response of treatment with respect to to the clinical features of Ama
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Figure-3, Response of treatment based on chief complaints using t-test
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Table 14: Comparison of parameters at different visit using Repeated measures ANOVA 
Parameters Base Line 
Visit 1 
(7th day) 
Visit 2 
(21st day) 
Visit 3 
(42nd day) 
Visit 4 
(57th day) 
p-value 
Das Score 6.545 ± 0.104a 6.210 ± 0.122b 5.524 ± 0.137c 4.897 ± 0.113d  < 0.001 
SF 36 187.66 ± 11.79a   615.74 ± 14.35b  < 0.001 
Global assessment  21.50 ± 1.372a 39.00 ± 1.69b 66.20 ± 1.92c 81.70 ± 1.66d  < 0.001 
ESR  49.56 ± 3.78 52.68 ± 4.67 53.10 ± 4.29 52.30 ± 4.38  0.575 
CRP  12.36 ± 1.88 11.51 ± 1.71 12.47 ± 1.84 11.23 ± 3.27  0.722 
HB 11.69 ± 0.203  11.76 ± 0.182 11.68 ± 0.192  0.767 
RA Factor 286.88 ± 73.19a  268.91 ± 70.44b 229.35 ± 55.27b  0.040 
ACCP 149.885 ± 23.87  146.40 ± 23.20 138.99 ± 20.61  0.374 
Number of joints 
involved 
23.08 ± 0.815a  19.70 ± 0.929b 9.48 ± 0.958c 3.94 ± 0.505d 
< 0.001 
Disability Index 1.689 ± 0.068a 1.300 ± 0.066b 0.628 ± 0.059c 0.354 ± 0.048d 0.310 ± 0.053d < 0.001 
Means having same letter as super script are homogeneous within a row
 DAS score obtained at different measurement 
time were subjected to kolmogorov Smirnov test for 
testing normality of the observations. P-value obtained 
for all the four measurements was found to be greater 
than 0.05 which indicates that the observation was 
normal and hence the parametric test namely repeated 
Analysis of variance was done to find out whether there 
is any difference in DAS score at different measurement 
period.  
Results show that there is significant difference 
in the DAS score measured at different days. Mean scores 
shows that DAS score is decreasing as the day 
progresses. 
Comparison of SF 36 score in first day with that 
of 42nd day was done by using paired t-test. Results show 
that there exists significant difference in SF36 score in 
first day and 42nd day. Mean score was higher in 42nd day 
which indicates that SF 36 score increased form first day 
to 42nd day. 
The Global assessment score in first day with 
that of 57th day was done and the result shows there 
exists significant difference in the first day and 57th day 
with mean score P < 0.001 which indicates that Global 
assessment increased from first day to 57th day. 
DISCUSSION AND CONCLUSION 
With reference to the ACR criteria and by using 
other internationally accepted scientific parameters, the 
evaluation of the Ayurvedic line of management for the 
disease has been formulated. Based on the Dosha dushya 
predominance and clinical features of the disease an 
initial course of Amapachana procedure for 7 days 
including specific medicines was administered. The 
medicines prescribed, Amruthotharam kwatha and 
Vaiswanara churna internally and Ruksha sweda 
externally is found to have significant effect in the acute 
stage of disease. The combination of Guluchi, Hareethaki 
and Shunti in specific proportion in Amruthotharam 
kwatha might have promoted the digestive process in 
Koshta and metabolic activities at Dhatu level. (anti-
inflammatory, immune system booster, anti rheumatic 
properties have already studied). In addition to that the 
Vaiswanara churna given internally for these days will 
also contributed for the same. To subside the “Ama” 
Ruksha ushna procedure are preferred. So during this 
period Rukshapottali sweda with Syamaka churna was 
done which is also effective to reduce pain and stiffness. 
It is established that Amapachana and further protection 
of Agni by promoting digestion is the best choice in the 
treatment of RA in its acute stage. No Snigdha prayoga is 
preferred during this stage which may trigger the 
symptoms provoking Doshas, Kapha and Vata. 
The next course of treatment in IPD was 
administration of Rasna sapthaka kwatha and Vyoshadi 
gulgulu internally and application of controlled Snigdha 
prayoga with Pathrapottali sweda externally. The 
internal medicines Rasna sapthaka Kwatha is the best 
choice for the relief of pain and swelling in joints as it is 
Sodhahara and anti inflammatory in action. The Vyoshadi 
gulgulu with the ingredients Thrikatu Chitraka, Musta, 
Thriphala, Vidanga and Guggulu are Ama pachana and 
Kaphamedohara also. It is very effective to improve the 
tissue level metabolism and the main ingredient Guggulu 
is already proved as an anti arthritis drug. The positive 
effect of Pathrapottali sweda in various rheumatic 
conditions have already established by clinical studies 
and practice. Swedana produces vasodilatation there by 
increased supply of nutrition to the site and the removal 
of debris or waste material generated due to the pre-
existed inflammatory process. It might have contributed 
for the positive response. 
More over the application of Pathrapottali sweda 
(Snigdhasweda) causes to reduces the stiffness and to 
improve the mobility of the joints.. The presence of 
Kapha has been subsided in this stage and Vata pitta or 
Rakta predominance may be observed. The assessment 
of result conducted with the given parameters to 
evaluate the functional improvement SF-36 score, Das 
score, Disability index and global assessment are showed 
highly significant changes compared with pre treatment 
period which establish the effect of the therapy. After the 
course of inpatient level treatment the patients were 
advised to continue the same medicines internally and 
application of medicated oil, Kottamchukkadi externally 
for 21 days. The statistical evaluation made by using the 
above parameters also established the sustainable effect 
of the treatment. 
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Lab investigation reports were compared to the 
pre-treatment period to that of post treatment results 
did not show significant changes. The functional 
improvement and feeling of well being of the patients 
observed is an indication that there is no much relevance 
to the values of the lab parameters in the assessment of 
functional improvement. It is also to be highlighted that 
the liver and kidney functions did not produce any 
adverse changes with above line of treatment. It clearly 
state that the prescribed treatment did not produce any 
adverse effect in the body systems and it is completely 
safe. 
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